Qiming Venture Partners

Qiming Venture Partners is a prominent venture capital firm based in Shanghai, China, with additional offices in Beijing, Suzhou, and Hong Kong. Founded in 2006, the firm specializes in investing in early to growth-stage companies across various sectors, including healthcare, information technology, consumer products, media, and clean technology. Qiming has established itself as a leading investment firm in China, managing multiple funds with over $1 billion in assets. The firm focuses on supporting innovative entrepreneurs and companies that demonstrate high growth potential, particularly in the technology and healthcare landscapes. Through its strategic investments, Qiming aims to foster the development of new business models and technologies, contributing to the dynamic entrepreneurial ecosystem in China.

Zhang Ao

Executive Director

Artavazd Arumov Ph.D

Principal

Ryan Baker

CFO

Cyrus Chan

Associate

Kan Chen

Partner

Liwen Chen

Associate

Nan Chen

Principal

David Chu

Partner

Phil DiGiacomo

Principal

Anna French

Managing Partner

Yuxin Fu

Associate

Jinda Gao

Principal

Kuantai Yeh

Partner

Robert Headley

Partner

Maykin Ho Ph.D

Venture Partner

William Hu

Managing Partner

Duane Kuang

Founding Managing Partner

Nisa Leung

Managing Partner

Lisa Li

Investor

Dingzheng Li

Vice President

Jing Liu

Associate

Chang Liu

Associate

Bin Liu

Associate

Biao Lu

Associate

Shuo Mao

Principal

Will Mcconnell

Principal

Mark McDade

Co-Founder and Managing Partner

Gary Rieschel

Founder and Managing Partner

Motao Sun

Associate

Amy Tang

Venture Partner

Yi Tang

Principal

Shiyu Wang

Partner

Shiyu Wang

Partner

Bonnie Wang

Principal

Rachel Wang

Venture Partner

Xin Wang

Investor

James Wang

Venture Partner

Gillian Xu

RMB funds CFO

Kuantai Yeh

Partner

Peter (Ming) Yin

Principal, Cleantech

Janet Yu Ph.D

Partner

Liang Yuyu

Managing Partner

Oscar Zhang

Principal

Yafeng Zhou

Associate

Alex Zhou

Managing Partner

Zhiyuan Zhou

Investor

Zhifeng Zhou

Managing Partner

Yiqing Zhu

Associate

Jing-Shan Hu Ph.D

Venture Partner of Healthcare

Phillip DiGiacomo Ph.D

Principal

Past deals in ASIC

CIX Technology

Seed Round in 2022
CIX Technology develops high-performance, next-generation intelligent computing solutions.

CIX Technology

Angel Round in 2022
CIX Technology develops high-performance, next-generation intelligent computing solutions.

Houmo.AI

Series A in 2022
Houmo.AI is a semiconductor company that develops an integrated circuit storage technology for AI computing. The company aims to use disruptive technologies to create AI chips with a "ten-fold effect", to meet the huge computing power demand in the era of true artificial intelligence, and to use unlimited computing power to change the world. Houmo.AI was founded by Dr. Wu Qiang in 2020.

Clique

Seed Round in 2022
Clique is building identity oracles that connect web2 user behavior data with web3 applications. We leverage advanced cryptographic tech like ZKP, TEE, and MPC to develop modular solutions with customizable privacy assumptions. Our main products are designed to help protocols, creators, and brands identify high-value users/fans, perform Sybil-resistant checks and distribute incentives accordingly. We already have 100+ partners across major L1/L2s, exchanges, marketplaces, NFT/GameFi/SocialFi projects, etc. We were previously incubated by Alliance DAO and Stanford Blockchain Accelerator and raised millions in funding from renowned VCs like GGV, Qiming, Infinity Ventures Crypto, Sky9, SevenX, Smrti Lab, etc. Our team has a strong technical background and comes from prestigious institutions like Duke, Cambridge, NUS, Tsinghua, Citi bank, Brevan Howard, etc. Our advisors include top cryptography researchers, past founders of established media companies, as well as famous Hollywood directors and writers.

ACXEL

Seed Round in 2022
ACXEL Tech develops large area electronics have given us flat panel displays and flexible, wearable devices. ACXEL takes these ‘active’ pixels and puts them to work transporting liquid droplets – precisely and at amazing speed. Millions of pixels are transformed into tiny engines moving samples around via a high throughput, low cost and programmable platform, offering a wide range of possibilities in chemistry, biology and medtech.

Axera

Series A in 2022
Developer of an artificial intelligence chip designed to focus on the visual field. The company's chip offers good performance with low power consumption, low-latency, and high-integration architecture system, enabling clients to have real-time video analysis on the terminal, good quality video shooting, and real-time multi-camera integration with low cost.

Xinchuangyuan Semiconductor

Series A in 2021
Xinchuangyuan Semiconductor is a manufacturing company of electronic equipment. Xinchuangyuan Semiconductor was founded in 2021 and was headquartered in Wuhan, China.

SUPERHEXA

Series A in 2021
Superhexa is a hardware company based in Beijing, founded on October 15, 2020, by Xia Yongfeng. It specializes in the development of personal consumer electronics, aiming to integrate technology seamlessly into everyday life. By focusing on innovation, Superhexa seeks to enhance the user experience and adapt to the evolving needs of consumers.

Atom Semiconductor

Venture Round in 2021
Atom Semiconductor is a scientific and technological enterprise focusing on digital sensor design. Atom Semiconductor was founded in 2020.

Clounix

Seed Round in 2021
Developer of application-specific integrated circuit (ASIC) designed for cloud networking. The company develops ASIC used for high speed packet switching, improving cloud networking technology.

Clounix

Seed Round in 2021
Developer of application-specific integrated circuit (ASIC) designed for cloud networking. The company develops ASIC used for high speed packet switching, improving cloud networking technology.

Houmo.AI

Seed Round in 2021
Houmo.AI is a semiconductor company that develops an integrated circuit storage technology for AI computing. The company aims to use disruptive technologies to create AI chips with a "ten-fold effect", to meet the huge computing power demand in the era of true artificial intelligence, and to use unlimited computing power to change the world. Houmo.AI was founded by Dr. Wu Qiang in 2020.

SUPERHEXA

Seed Round in 2021
Superhexa is a hardware company based in Beijing, founded on October 15, 2020, by Xia Yongfeng. It specializes in the development of personal consumer electronics, aiming to integrate technology seamlessly into everyday life. By focusing on innovation, Superhexa seeks to enhance the user experience and adapt to the evolving needs of consumers.

Matrixport

Series C in 2021
Matrixport is a comprehensive platform that facilitates the trading, custody, investment, and borrowing of cryptocurrency assets. Headquartered in Singapore, the company leverages advanced technology and industry expertise to provide a range of services, including digital currency trading, institutional custody, and cryptocurrency lending. Matrixport's mission is to foster a more open and equitable financial system by utilizing blockchain technologies. With a focus on client empowerment, the platform aims to offer innovative financial products to users worldwide, thereby enabling them to take control of their finances and capital.

Axera

Seed Round in 2021
Developer of an artificial intelligence chip designed to focus on the visual field. The company's chip offers good performance with low power consumption, low-latency, and high-integration architecture system, enabling clients to have real-time video analysis on the terminal, good quality video shooting, and real-time multi-camera integration with low cost.

imToken

Series B in 2021
imToken Pte. Ltd. is a Singapore-based company that specializes in developing a blockchain-based cryptocurrency wallet and digital asset management tools. Founded in 2016, imToken enables users to manage multi-chain assets and facilitates secure token exchanges within its wallet. The platform features a DApp browser that supports decentralized token-to-token transactions, enhancing the user experience in the blockchain ecosystem. Over the years, imToken has garnered a global user base, becoming one of the largest Ethereum wallets in the world. The company operates as a subsidiary of Hangzhou Rongshi Technology Co., Ltd. and is dedicated to making blockchain technology accessible and user-friendly for a broader audience.

Casela

Series A in 2021
Casela is a chip and semiconductor company

Bouffalo Lab

Series B in 2021
Bouffalo Lab is a semiconductor chip design company based in Shanghai, China, specializing in the development of integrated Wi-Fi chipsets and a comprehensive range of Internet of Things (IoT) solutions. The company's products are tailored for applications in smart homes, smart cities, manufacturing, robotics, communication equipment, and intelligent systems for vehicles and wearables. Bouffalo Lab's chips are designed to support low-power wireless microcontrollers and application processor platforms, enabling efficient and high-performance operation across various sectors.

RFoneTech

Series A in 2021
Developer and seller of radio frequency (RF) integrated circuit products. The company focuses on the combination of process development, model development and product design of RF front-end chips and modules, and its RF integrated circuit products are widely used in 5G mobile communications and Internet of Things equipment.

HashQuark

Series A in 2020
HashQuark is a provider of staking and blockchain infrastructure services, specializing in the Proof of Stake (PoS) and Delegated Proof of Stake (DPoS) ecosystems. Founded in 2018 and based in Grand Cayman, the company offers a range of services including staking for institutions, individuals, and market professionals, as well as a Staking Cloud that enables token holders to securely store their tokens and earn staking rewards. HashQuark supports all mainstream PoS blockchains and has completed global server deployment, ensuring secure and stable operations for its clients. The company's focus is on providing efficient node management and fostering investment opportunities for both individual and institutional investors within the blockchain space.

Biren Technology

Series A in 2020
Biren Technology, based in Shanghai, China, specializes in the design and manufacture of intelligent chips and processors tailored for various computing architectures, including GPU and DSA. The company operates in the high-tech sector, focusing on both hardware and software solutions. Its hardware division develops a range of computing solutions that blend versatility with specificity, while its software department is led by experienced industry professionals. The company also conducts frontier research on new intelligent computing systems, emphasizing innovative architectures and advanced compilation technologies. Biren Technology aims to provide integrated solutions for applications such as cloud computing, artificial intelligence training, graphics rendering, and high-performance general-purpose computing, enabling clients to utilize domestic chip solutions and achieve significant technological advancements.

Bouffalo Lab

Series B in 2020
Bouffalo Lab is a semiconductor chip design company based in Shanghai, China, specializing in the development of integrated Wi-Fi chipsets and a comprehensive range of Internet of Things (IoT) solutions. The company's products are tailored for applications in smart homes, smart cities, manufacturing, robotics, communication equipment, and intelligent systems for vehicles and wearables. Bouffalo Lab's chips are designed to support low-power wireless microcontrollers and application processor platforms, enabling efficient and high-performance operation across various sectors.

Casela

Series A in 2019
Casela is a chip and semiconductor company

APT Medical

Venture Round in 2019
APT Medical Inc. is a high-tech enterprise focused on the research, development, manufacture, and sale of minimally invasive interventional medical devices targeting cardiovascular and cerebrovascular diseases. The company offers a range of products, including electrophysiological catheter delivery systems, radiofrequency ablation and mapping catheters, as well as various vascular intervention products and accessories. APT Medical also provides OEM and ODM services for catheter and metal products. Founded in 2002 and headquartered in Shenzhen, China, the company operates production facilities in Guanlan, Shenzhen, and Xiangxiang, Hunan, and markets its products across Europe, Eastern Europe, Southeast Asia, and other regions worldwide.

ACEA BIO

Venture Round in 2019
ACEA Biosciences, Inc. is a biotechnology company based in San Diego, California, specializing in the development and commercialization of advanced microelectronic sensor systems for cell-based assays, drug discovery, and diagnostics. Founded in 2002, ACEA has pioneered real-time, label-free cell-based assay technology, marketed under the xCELLigence brand. Its product lineup includes the x-CELLigence System for various applications in biomedicine and pharmaceuticals, CIM systems for real-time monitoring of cell migration, and several RTCA instruments for cardiotoxicity testing and impedance measurement. The company serves a global customer base of over 800 clients and has contributed to more than 350 peer-reviewed publications. Additionally, ACEA has a Therapeutics Business Unit focusing on oncology drug discovery, leveraging its biosensor technology and a proprietary library of over one million compounds. Currently, ACEA has a program in phase II clinical trials in China, underlining its commitment to innovation in the research and healthcare sectors. The company operates manufacturing facilities in Hangzhou, China, and is a subsidiary of Agilent Technologies, Inc.

APT Medical

Series C in 2018
APT Medical Inc. is a high-tech enterprise focused on the research, development, manufacture, and sale of minimally invasive interventional medical devices targeting cardiovascular and cerebrovascular diseases. The company offers a range of products, including electrophysiological catheter delivery systems, radiofrequency ablation and mapping catheters, as well as various vascular intervention products and accessories. APT Medical also provides OEM and ODM services for catheter and metal products. Founded in 2002 and headquartered in Shenzhen, China, the company operates production facilities in Guanlan, Shenzhen, and Xiangxiang, Hunan, and markets its products across Europe, Eastern Europe, Southeast Asia, and other regions worldwide.

Akulaku

Series C in 2018
Akulaku Inc. is a consumer finance platform based in Jakarta, Indonesia, established in 2016. The company specializes in offering online financial credit services to customers across Southeast Asia. Its services include shopping in installments through an independently managed online marketplace and various other platforms, as well as providing flexible cash loans. Akulaku's mission is to enhance the quality of life for both partners and consumers by creating a comprehensive and reliable financial ecosystem.

APT Medical

Series B in 2018
APT Medical Inc. is a high-tech enterprise focused on the research, development, manufacture, and sale of minimally invasive interventional medical devices targeting cardiovascular and cerebrovascular diseases. The company offers a range of products, including electrophysiological catheter delivery systems, radiofrequency ablation and mapping catheters, as well as various vascular intervention products and accessories. APT Medical also provides OEM and ODM services for catheter and metal products. Founded in 2002 and headquartered in Shenzhen, China, the company operates production facilities in Guanlan, Shenzhen, and Xiangxiang, Hunan, and markets its products across Europe, Eastern Europe, Southeast Asia, and other regions worldwide.

Wacai

Series D in 2018
Wacai is a Chinese mobile app developer and the creator of a personal finance management mobile app. The app has two major functions. One, to serve as a bookkeeping service (launched in 2009) and two, a mutual fund trading feature that was added in July of 2013. Its most recent feature, incorporated in April of 2014, is a credit card manager, which is gaining popularity in the Chinese markets. The app currently has over 40 million users.

AI-Prime

Series A in 2018
AI-Prime is a company based in Shanghai, China, that specializes in artificial intelligence-driven safety solutions for industrial environments. It offers a cloud-based software-as-a-service platform that integrates with camera systems to enhance workplace safety. The company's technology focuses on identifying direct threats and provides data-driven insights and reports that facilitate a continuous feedback loop. This approach enables various industries to automate safety measures and improve operational efficiency. AI-Prime's commitment to creating safer working environments positions it as a key player in the field of industrial security solutions.

ACEA BIO

Series E in 2018
ACEA Biosciences, Inc. is a biotechnology company based in San Diego, California, specializing in the development and commercialization of advanced microelectronic sensor systems for cell-based assays, drug discovery, and diagnostics. Founded in 2002, ACEA has pioneered real-time, label-free cell-based assay technology, marketed under the xCELLigence brand. Its product lineup includes the x-CELLigence System for various applications in biomedicine and pharmaceuticals, CIM systems for real-time monitoring of cell migration, and several RTCA instruments for cardiotoxicity testing and impedance measurement. The company serves a global customer base of over 800 clients and has contributed to more than 350 peer-reviewed publications. Additionally, ACEA has a Therapeutics Business Unit focusing on oncology drug discovery, leveraging its biosensor technology and a proprietary library of over one million compounds. Currently, ACEA has a program in phase II clinical trials in China, underlining its commitment to innovation in the research and healthcare sectors. The company operates manufacturing facilities in Hangzhou, China, and is a subsidiary of Agilent Technologies, Inc.

Bouffalo Lab

Series A in 2018
Bouffalo Lab is a semiconductor chip design company based in Shanghai, China, specializing in the development of integrated Wi-Fi chipsets and a comprehensive range of Internet of Things (IoT) solutions. The company's products are tailored for applications in smart homes, smart cities, manufacturing, robotics, communication equipment, and intelligent systems for vehicles and wearables. Bouffalo Lab's chips are designed to support low-power wireless microcontrollers and application processor platforms, enabling efficient and high-performance operation across various sectors.

Akulaku

Series B in 2017
Akulaku Inc. is a consumer finance platform based in Jakarta, Indonesia, established in 2016. The company specializes in offering online financial credit services to customers across Southeast Asia. Its services include shopping in installments through an independently managed online marketplace and various other platforms, as well as providing flexible cash loans. Akulaku's mission is to enhance the quality of life for both partners and consumers by creating a comprehensive and reliable financial ecosystem.

Wacai

Series C in 2017
Wacai is a Chinese mobile app developer and the creator of a personal finance management mobile app. The app has two major functions. One, to serve as a bookkeeping service (launched in 2009) and two, a mutual fund trading feature that was added in July of 2013. Its most recent feature, incorporated in April of 2014, is a credit card manager, which is gaining popularity in the Chinese markets. The app currently has over 40 million users.

APT Medical

Series A in 2016
APT Medical Inc. is a high-tech enterprise focused on the research, development, manufacture, and sale of minimally invasive interventional medical devices targeting cardiovascular and cerebrovascular diseases. The company offers a range of products, including electrophysiological catheter delivery systems, radiofrequency ablation and mapping catheters, as well as various vascular intervention products and accessories. APT Medical also provides OEM and ODM services for catheter and metal products. Founded in 2002 and headquartered in Shenzhen, China, the company operates production facilities in Guanlan, Shenzhen, and Xiangxiang, Hunan, and markets its products across Europe, Eastern Europe, Southeast Asia, and other regions worldwide.

Aiqi Technology

Venture Round in 2016
Beijing AIQI Technology Co., Ltd. is an Internet technology company founded in 2013 and based in Beijing, China. The company specializes in the research and development of artificial intelligence and robotic technology, focusing on the creation of DIY intelligent robots. AIQI has developed a range of interactive robots aimed at K-12 STEM education, promoting human-machine interaction and creativity among users. In recent years, the company has secured numerous patents in intelligent equipment and established a partnership with the technology giant Xiaomi, becoming the sole provider of DIY intelligent robots within Xiaomi's ecosystem. With a strong research team and advanced production capabilities, AIQI Technology aims to deliver innovative and user-friendly robotic solutions that enhance modern life.

ACEA BIO

Series E in 2016
ACEA Biosciences, Inc. is a biotechnology company based in San Diego, California, specializing in the development and commercialization of advanced microelectronic sensor systems for cell-based assays, drug discovery, and diagnostics. Founded in 2002, ACEA has pioneered real-time, label-free cell-based assay technology, marketed under the xCELLigence brand. Its product lineup includes the x-CELLigence System for various applications in biomedicine and pharmaceuticals, CIM systems for real-time monitoring of cell migration, and several RTCA instruments for cardiotoxicity testing and impedance measurement. The company serves a global customer base of over 800 clients and has contributed to more than 350 peer-reviewed publications. Additionally, ACEA has a Therapeutics Business Unit focusing on oncology drug discovery, leveraging its biosensor technology and a proprietary library of over one million compounds. Currently, ACEA has a program in phase II clinical trials in China, underlining its commitment to innovation in the research and healthcare sectors. The company operates manufacturing facilities in Hangzhou, China, and is a subsidiary of Agilent Technologies, Inc.

Aiqi Technology

Series A in 2016
Beijing AIQI Technology Co., Ltd. is an Internet technology company founded in 2013 and based in Beijing, China. The company specializes in the research and development of artificial intelligence and robotic technology, focusing on the creation of DIY intelligent robots. AIQI has developed a range of interactive robots aimed at K-12 STEM education, promoting human-machine interaction and creativity among users. In recent years, the company has secured numerous patents in intelligent equipment and established a partnership with the technology giant Xiaomi, becoming the sole provider of DIY intelligent robots within Xiaomi's ecosystem. With a strong research team and advanced production capabilities, AIQI Technology aims to deliver innovative and user-friendly robotic solutions that enhance modern life.

ACEA BIO

Venture Round in 2015
ACEA Biosciences, Inc. is a biotechnology company based in San Diego, California, specializing in the development and commercialization of advanced microelectronic sensor systems for cell-based assays, drug discovery, and diagnostics. Founded in 2002, ACEA has pioneered real-time, label-free cell-based assay technology, marketed under the xCELLigence brand. Its product lineup includes the x-CELLigence System for various applications in biomedicine and pharmaceuticals, CIM systems for real-time monitoring of cell migration, and several RTCA instruments for cardiotoxicity testing and impedance measurement. The company serves a global customer base of over 800 clients and has contributed to more than 350 peer-reviewed publications. Additionally, ACEA has a Therapeutics Business Unit focusing on oncology drug discovery, leveraging its biosensor technology and a proprietary library of over one million compounds. Currently, ACEA has a program in phase II clinical trials in China, underlining its commitment to innovation in the research and healthcare sectors. The company operates manufacturing facilities in Hangzhou, China, and is a subsidiary of Agilent Technologies, Inc.

Wacai

Series B in 2015
Wacai is a Chinese mobile app developer and the creator of a personal finance management mobile app. The app has two major functions. One, to serve as a bookkeeping service (launched in 2009) and two, a mutual fund trading feature that was added in July of 2013. Its most recent feature, incorporated in April of 2014, is a credit card manager, which is gaining popularity in the Chinese markets. The app currently has over 40 million users.

Wacai

Series B in 2014
Wacai is a Chinese mobile app developer and the creator of a personal finance management mobile app. The app has two major functions. One, to serve as a bookkeeping service (launched in 2009) and two, a mutual fund trading feature that was added in July of 2013. Its most recent feature, incorporated in April of 2014, is a credit card manager, which is gaining popularity in the Chinese markets. The app currently has over 40 million users.

Intelligent Automation

Series B in 2014
Intelligent Automation was founded in 2006 in Zhuhai. In 2015 they became the famous list firm CYG’s subsidiary and stock code is 600525.SH. They have been focusing on the research and development of high-end automatic test equipment and assembly equipment. Hitherto they have provided their high quality solution on the industries of consumer electronic, automotive, medical, new energy and LED lighting, industry.

APT Medical

Series A in 2014
APT Medical Inc. is a high-tech enterprise focused on the research, development, manufacture, and sale of minimally invasive interventional medical devices targeting cardiovascular and cerebrovascular diseases. The company offers a range of products, including electrophysiological catheter delivery systems, radiofrequency ablation and mapping catheters, as well as various vascular intervention products and accessories. APT Medical also provides OEM and ODM services for catheter and metal products. Founded in 2002 and headquartered in Shenzhen, China, the company operates production facilities in Guanlan, Shenzhen, and Xiangxiang, Hunan, and markets its products across Europe, Eastern Europe, Southeast Asia, and other regions worldwide.

Wacai

Series A in 2014
Wacai is a Chinese mobile app developer and the creator of a personal finance management mobile app. The app has two major functions. One, to serve as a bookkeeping service (launched in 2009) and two, a mutual fund trading feature that was added in July of 2013. Its most recent feature, incorporated in April of 2014, is a credit card manager, which is gaining popularity in the Chinese markets. The app currently has over 40 million users.

Intelligent Automation

Series A in 2013
Intelligent Automation was founded in 2006 in Zhuhai. In 2015 they became the famous list firm CYG’s subsidiary and stock code is 600525.SH. They have been focusing on the research and development of high-end automatic test equipment and assembly equipment. Hitherto they have provided their high quality solution on the industries of consumer electronic, automotive, medical, new energy and LED lighting, industry.

Aeonmed

Series A in 2010
Aeonmed Medical Treatment (至尊租车) is a manufacturer and supplier of operating theatre and ICU devices, and medical treatment system solutions. Since its foundation, Aeonmed has always been guided by the clinical demands, and dedicated to the study of clinical medical equipment and solutions. Now, Aeonmed business covers three major product portfolios, including anesthesia and operation support, emergency and critical care and medical engineering equipment, and five major medical system solutions including laminar flow monitoring, environment and equipment configuration, centralized gas supply, process quality control and information integration. Currently, Aeon has more than 600 authorized and declared patents, among which there are more than 400 patents for invention, maintaining an increase of over 100 patents each year.

Fangtek

Series C in 2006
Shanghai Fangtek Electronics Co., Ltd. is an integrated circuit design company based in Shanghai, China, with an additional office in Shenzhen. Founded in 2003, Fangtek specializes in the design, development, and marketing of analog and mixed-signal power management integrated circuits. Its product offerings include audio power amplifiers, LED drivers, SIM card controllers, analog switches, reset integrated circuits, charger protection products, and voltage regulators. These products cater to various applications in the communication, computing, and consumer electronics sectors, including mobile phones, GPS devices, and audio equipment. Fangtek is committed to delivering innovative, high-performance, and cost-effective solutions, leveraging its expertise in power device technology and mixed-signal design to serve the needs of industries focused on audio, lighting, and voltage regulation.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.